The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
10.27
-0.02 (-0.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
The Joint Market Cap
The Joint has a market cap or net worth of $153.88 million as of December 20, 2024. Its market cap has increased by 13.90% in one year.
Market Cap
153.88M
Enterprise Value
142.57M
1-Year Change
13.90%
Ranking
Category
Stock Price
$10.27
Market Cap Chart
Since November 11, 2014, The Joint's market cap has increased from $60.30M to $153.88M, an increase of 155.19%. That is a compound annual growth rate of 9.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 153.90M | 8.53% |
| Dec 29, 2023 | 141.80M | -30.18% |
| Dec 30, 2022 | 203.10M | -78.55% |
| Dec 31, 2021 | 946.80M | 156.79% |
| Dec 31, 2020 | 368.70M | 64.75% |
| Dec 31, 2019 | 223.80M | 95.80% |
| Dec 31, 2018 | 114.30M | 70.34% |
| Dec 29, 2017 | 67.10M | 99.11% |
| Dec 30, 2016 | 33.70M | -42.98% |
| Dec 31, 2015 | 59.10M | -4.68% |
| Dec 31, 2014 | 62.00M | 2.82% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 158.11M |
| Seres Therapeutics | 156.31M |
| Cellectis | 155.56M |
| Sutro Biopharma | 155.02M |
| Adaptimmune Therapeutics | 154.78M |
| Telomir Pharmaceuticals | 153.38M |
| Biomea Fusion | 153.29M |
| Metagenomi | 151.57M |